Abstract
Introduction
Ventral hernia repair (VHR) is one of the most common procedures in the United States, and drains are used in over 50% of mesh repairs. The aim of this study is to investigate the impact of drains on surgical site occurrences (SSO) and infection (SSI) after open and minimally invasive retromuscular VHR with mesh.
Methods
A retrospective review of prospectively collected data from the ACHQC was performed to include adult patients who underwent elective VHR with retromuscular mesh placement. Univariate analysis was performed comparing drain and no-drain groups. A logistic regression was performed to identify factors independently associated with increased SSO, SSI, readmission, and length of stay (LOS).
Results
6945 patients underwent elective VHR with sublay mesh. Most patients had M2 and M3 hernias in both groups (with Drain and no-drain). The median LOS was 4.7 (SD 8.3) in the drain group and 1.6 (SD 8.4) in the no-drain group (p < 0.001). 30-day SSI was higher in the drain group (176; 3.8% vs 25; 1.1%; p < 0.001). Despite lower SSO overall in the drain group (470; 10.0% vs 286; 12.7%; p < 0.001), SSO or SSI requiring intervention (SSOPI) was higher in the drain group (240; 5.1% vs 44; 1.9%; p < 0.001). Logistic regression identified diabetes (OR 1.3, CI 1.1–1.6; p < 0.001) and BMI (OR 1.04, CI 1.03–1.05; p < 0.001) as predictors of SSO, while the use of a drain was protective (OR 0.61; CI 0.5–0.8; p < 0.001). For SSI, logistic regression showed diabetes (OR 1.6, CI 1.2–2.3; p = 0.004) and open approach (OR 3.5, CI 2.1–5.9; p < 0.001) as predictors.
Conclusions
Drain placement during retromuscular VHR with mesh was predictive of decreased postoperative SSO occurrence but associated with increased LOS. Diabetes and open approach, but not drain use, were predictors of SSI.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Retromuscular mesh placement in ventral hernia repair (VHR) increased over the past decade [1,2,3]. Placement of mesh in contact with highly vascularized muscle promotes mesh-tissue integration, improving the durability of the repair and decreasing complication rates when compared to onlay and inlay repairs [4, 5]. Recently, minimally invasive techniques have been developed and refined to accomplish this repair by developing a large retromuscular space in the abdominal wall that allows for adequate mesh overlap of the hernia defect [6,7,8]. However, the creation of this space may also increase the risk for seroma, hematoma, surgical site infection (SSI), and early readmission [9, 10].
Drains placed during retromuscular VHR aims to decrease the risk of seroma formation. However, there is no consensus in the literature or guidelines regarding their use. Some studies suggest that drains can increase the risk of infection [11, 12], while others demonstrate advantages in decreasing the risk of seroma formation [13, 14]. A recent meta-analysis found that retromuscular drain placement reduces seroma formation with no increased risk of infection [15].
Few studies in the literature investigated the role of drains specifically in retromuscular VHR [4, 13, 14]. The aim of this study is to investigate the drain’s impact on surgical site occurrences (SSO) and infections (SSI) after open and minimally invasive retromuscular VHR with mesh.
Methods
Data collection
The data for this study were originated from the Abdominal Core Health Quality Collaborative (ACHQC) from January 2013 to November 2022. The ACHQC is a nationwide hernia registry currently comprised of 442 participant surgeons across the United States from both academic and private institutions. Prospectively entered patient information includes demographics, preoperative information, operative details, and postoperative details with patient reported outcomes (PROs). As of early 2023, there are a total of 113,898 patients listed in the database who underwent ventral, lateral, and inguinal hernia repairs with 30-day and 1-year follow-ups.
Population, comparison groups, and baseline variables
The objective of this study is to investigate the impact of drain placement on SSO and SSI after open and minimally invasive retromuscular VHR with mesh. We selected all elective open, laparoscopic, and robotic-assisted VHR s with retromuscular mesh placement in the ACHQC (Fig. 1). We excluded patients with concomitant inguinal hernia repairs, repairs in contaminated and dirty fields (CDC Class III and IV), repairs with no mesh, or patients with prior mesh. We also excluded patients who had no 30-day follow-up data. Drain usage was collected in the ACHQC database, and patients were categorized as with or without drain accordingly.
Baseline characteristics assessed were age, gender, race, BMI, diabetes, hypertension, chronic obstructive pulmonary disease, anti-platelet medications, ASA class, European Hernia Society hernia classification midline component, hernia size, hernia length, hernia width, current smoker within 1 month, number of meshed used, fixation type, myofascial release (transversus abdominis) performed, and mesh type. 0.1% patients had no assigned ASA class. They were combined with patients with ASA class = 4 to facilitate modeling. Hernia size was calculated based on hernia length and hernia width with the following formula: \(\frac{{\text{length}}}{2}\times \frac{{\text{width}}}{2}\times \pi .\)
Outcomes
The primary outcomes of this study are wound morbidities after VHR. SSO, SSI, surgical site occurrence requiring procedural intervention (SSOPI), and seroma are of particular interest. Surgical site infection is defined as infections occurring up to 30 days after surgery and affecting either the incision or deep tissue at the operation site [16]. SSO includes any SSI, as well as wound cellulitis, nonhealing incisional wound, fascial disruption, skin or soft tissue ischemia, skin or soft tissue necrosis, wound serous or purulent drainage, stitch abscess, seroma, hematoma, infected or exposed mesh, or development of an enterocutaneous fistula. SSOPI is defined as any SSO that requires wound opening, wound debridement, suture excision, percutaneous drainage, and partial or complete mesh removal. Secondary outcomes were length of stay (LOS) and readmission at 30 days after surgery.
Statistical analysis
Categorical variables were presented as frequency and percentage and compared across groups using Pearson Chi-squared tests or Fisher exact tests, and continuous variables were presented as the median and interquartile range (IQR) and compared across groups using Wilcoxon rank sum tests. We dichotomized the LOS using the median before the regression analysis. Multivariable logistic models were built to evaluate independent factors associated with endpoints adjusting for all baseline characteristics except for hernia width and length, because they correlated with hernia size. Odds ratios with a 95% confidence interval were reported. A p value < 0.05 was considered statistically significant. All statistical analysis was performed using R Statistical Software, version 4.2.3 (R Foundation for Statistical Computing).
Institutional review board
This study was approved by our Institutional Review Board (IRB) Number #2022-13807.
Results
Patient characteristics
The ACHQC database identified 6945 patients who underwent elective VHR with sublay mesh (Fig. 1). We divided the patients into two groups: 4687 patients with drains and 2258 patients without drains. Demographic and descriptive data are shown in Table 1. The mean age was 58.3 (SD 12.6) years in patients with drains vs 57.1 (SD 13.5) years in the no-drain group (p < 0.001). There was no difference in mean BMI between the groups [32.1 kg/m2 (SD 6.5) in the drain group vs 32.4 kg/m2 (SD 6.9) in the no-drain group (p = 0.697)]. Smoking was higher in the no drain group (n = 223; 10%) vs (n = 391; 8.4%) in the drain group (p = 0.039) and DM was higher in the drain group (20.6%) vs (18.6%) in the no-drain group (p = 0.062) (Table 1).
Hernia characteristics
Most patients had M2 and M3 hernias (according to the EHS classification) in both groups. Mean defect area was 177 (SD 151) cm2 in the drain group vs 53.9 (SD 59.8) cm2 in the no-drain group (p < 0.001). The drain group had more patients with 2 meshes (248; 5.3%) when compared with the no-drain group (40; 1.8%) (p < 0.001) (Table 2).
Perioperative outcomes
The surgical approach was open in the group with drain in 3946 (84.2%) vs 701 (31%) in the no-drain group (p < 0.001). Component separation, such as TAR, was also higher in the drain group (3115; 66.5%) vs the no-drain group (526; 23.3%) (p < 0.001). In most cases, the permanent synthetic mesh was used in both groups, and resorbable synthetic mesh use was higher in the drain group (Table 2).
The median LOS was 4.7 days (IQR 2–6) in the drain group and 1.6 days (IQR 0–2) in the no-drain group (p < 0.001) (Table 2). The readmission rate was higher in the drain group (n = 285; 6.1% vs n = 76; 3.4%; p < 0.001). 30-day SSI was higher in the drain group (176; 3.8% vs 25; 1.1%; p < 0.001). Despite lower SSO overall in the drain group (47; 10% vs 286; 12.7%; p < 0.001), SSO requiring intervention (SSOPI) was higher (240; 5.1% vs 44; 1.9%; p < 0.001). Seroma was higher in the no-drain group (n = 235; 10.4%) vs 171 (3.6%) patients in the drain group (p < 0.001) (Table 2).
Multivariate analysis
A multivariate model was built to evaluate independent factors associated with wound morbidity (SSO, SSI, LOS, SSOPI and seroma). Regarding LOS, logistic regression demonstrated drain use (OR 2.8, CI 2.31–3.738; p < 0.001), open approach (OR 7.28, CI 6.05–8.79; p < 0.001) and TAR (OR 2.3, 95% CI 1.94–2.62; p < 0.001) were strongly associated with longer LOS (Table 3). Regarding 30-day readmissions, drain use was not associated with readmissions in 30 days after surgery (OR 1.08; 95% CI 0.8–1.52; p = 0.663) (Table 3). Drain was not associated with SSI (OR 1.37; 95% CI 0.83–2.32; p = 0.227). All variables included in the model are listed in Table 4. Logistic regression identified diabetes (OR 1.3, CI 1.1–1.57; p = 0.005, and COPD (OR 1.35, 95% CI 1.02–1.8; p = 0.005) as predictors of SSO, while use of a drain was protective (OR 0.61; 95% CI 0.5–0.8; p < 0.001) (Table 5). Finally, drain use was associated with preventing seroma formation at 30 days (OR 0.34; 95% CI 0.25–0.45; p < 0.001). Surprisingly, the open approach was associated with lower seroma formation (OR 0.71; 95% CI 0.54–0.93; p = 0.013) (Table 6).
Discussion
This study is the first large-scale study to evaluate the drain use in both open and minimally invasive retromuscular VHR with mesh. Using the ACHQC database, we found that drain use is associated with longer LOS but is not independently associated with increased risk for SSI, SSO, or readmission. Furthermore, drain was a protective factor against SSO and seroma formation specifically. These findings are corroborated by other published studies with smaller samples.
A previous study by Krpata and colleagues using the same database in 2017 only investigated the use of drains after open retromuscular repair [14]. The authors performed Propensity Score Matching (PSM) of 300 patients and also found, using a logistic regression model, retromuscular drains were not associated with SSI (OR, 1.30; 95% CI 0.33–5.21) or SSOPI (OR, 0.94; 95% CI 0.29–3.01) and patients were less likely to develop SSO (OR, 0.33; 95% CI 0.14–0.78). In addition, they found that seroma formation was higher in patients that did not have drains (8.0 vs 1.0%; p < 0.01). A more recent study by Miller et al. using the same database but only patients who underwent robotic retromuscular VHR showed that patients with drains had fewer seromas and drain placement lowered the risk of an SSO compared to no drain placement (OR 0.32, CI 0.21–0.47; p < 0.0001) [13]. They also showed that the LOS was longer for patients with drains (2.0 days [IQR 1.0; 3.0] vs 1.0 days [IQR 1.0; 2.0], respectively; p < 0.0001). We similarly found that patients with drains had a mean LOS of 4.7 days (SD 8.3) vs 1.6 (SD 8.3) days for those without (p < 0.001).
Due to a lack of scientific evidence or definitive consensus guidelines, drain use is primarily driven by individual surgeon preference and experience. This may result in a selection bias favoring the use of drains in more complex cases [17]. In this study, the drain group had more complex hernias and higher rates of component separation when compared with the no-drain group. Patients with bigger and more complex hernias are more likely to need component separation, such as TAR, to reconstitute the linea alba [18,19,20,21,22]. In this study, patients who had TAR had a higher risk of infection. Furthermore, the open approach was associated with a higher risk of SSI, 30-day readmission, and longer LOS.
A retrospective study published by Arora et al. using the Abdominal Wall Reconstruction Surgical Collaborative (AWRSC) registry evaluated the use of drains in 120 patients who underwent enhanced-view totally extraperitoneal (eTEP) retromuscular repairs [4]. Like our findings, they noted longer LOS with the drain use, found no significant difference regarding SSO or SSI, and their drain group had a higher risk of SSOPI.
Willemin and colleagues published the only randomized clinical trial with 144 patients who underwent open retromuscular incisional hernia repair. They found no difference between the groups in the fluid collection at 30 days (60.3% vs 62%) and fewer surgical complications and wound dehiscence in the drain group [23]. In their study, the prophylactic drainage in open incisional retromuscular hernia repair did not reduce the rate of postoperative seroma.
Systematic reviews and meta-analysis
A recent meta-analysis by Marcolin et al. (2023) included only three observational studies and one randomized clinical trial with 1724 patients [15]. The authors found that drain placement was associated with decreased seroma formation (OR 0.34; 95% CI 0.12–0.96; p = 0.04). However, there was no difference in SSI, SSO, and SSOPI. Important limitations of this study are the low number of studies included, only one of which was a randomized controlled trial, and differences in how seroma is evaluated between studies (retromuscular or subcutaneous) despite the drain being placed in the retromuscular space. As more retrospective and prospective studies are published, future meta-analysis can be performed to better understand the role of drains in the retromuscular space.
Novelty of this study
This study uses a national database with surgeons from all parts of the country. It reinforces the findings of other retrospective studies with smaller sample sizes and the most recent meta-analysis that showed advantages of using drains to decrease the risk of seroma formation with no increased risk of infection. In addition, this study is the first to evaluate drains in open and minimally invasive approach repairs using permanent and resorbable synthetic meshes.
Limitations and strength of this study
This study has several limitations. It is a retrospective study with prospective data entered by the surgeons who input their data into the ACHQC database. This may lead to recall bias. Second, a performance bias might be present as dedicated abdominal wall repair surgeons are more likely to participate in data collection. Another important limitation is that the ACHQC database does not collect drain removal timing or antibiotic use duration. Finally, the data are collected through voluntary self-reporting, so there may be selection bias if participating surgeons input only some of their cases. The strength of this study lies in our large sample size (N = 7104) and the multivariate analysis to identify independent factors associated with wound morbidity after retromuscular repairs. Using multivariate analysis allowed for the interpretation of odds ratios of individual events while controlling for other covariates.
Conclusion
Drain placement during retromuscular VHR with mesh was predictive of decreased postoperative SSO occurrence but associated with increased LOS. Diabetes and open approach, but not drain use, were predictors of SSI.
References
Bracale U, Corcione F, Neola D, Castiglioni S, Cavallaro G, Stabilini C et al (2021) Transversus abdominis release (TAR) for ventral hernia repair: open or robotic? Short-term outcomes from a systematic review with meta-analysis. Hernia 25(6):1471–1480
Holihan JL, Nguyen DH, Nguyen MT, Mo J, Kao LS, Liang MK (2016) Mesh location in open ventral hernia repair: a systematic review and network meta-analysis. World J Surg 40(1):89–99
Köckerling F, Hoffmann H, Mayer F, Zarras K, Reinpold W, Fortelny R et al (2021) What are the trends in incisional hernia repair? Real-world data over 10 years from the Herniamed registry. Hernia 25(2):255–265
Arora E, Mishra A, Mhaskar R, Mahadar R, Gandhi J, Sharma S et al (2022) Are drains useful in eTEP ventral hernia repairs? An AWR surgical collaborative (AWRSC) retrospective study. Surg Endosc 36(10):7295–7301
Venclauskas L, Maleckas A, Kiudelis M (2010) One-year follow-up after incisional hernia treatment: results of a prospective randomized study. Hernia 14(6):575–582
Belyansky I, Daes J, Radu VG, Balasubramanian R, Reza Zahiri H, Weltz AS et al (2018) A novel approach using the enhanced-view totally extraperitoneal (eTEP) technique for laparoscopic retromuscular hernia repair. Surg Endosc 32(3):1525–1532
Lu R, Addo A, Ewart Z, Broda A, Parlacoski S, Zahiri HR et al (2020) Comparative review of outcomes: laparoscopic and robotic enhanced-view totally extraperitoneal (eTEP) access retrorectus repairs. Surg Endosc 34(8):3597–3605
Belyansky I, Reza Zahiri H, Sanford Z, Weltz AS, Park A (2018) Early operative outcomes of endoscopic (eTEP access) robotic-assisted retromuscular abdominal wall hernia repair. Hernia 22(5):837–847
Kaafarani HMA, Hur K, Hirter A, Kim LT, Thomas A, Berger DH et al (2009) Seroma in ventral incisional herniorrhaphy: incidence, predictors and outcome. Am J Surg 198(5):639–644
Stoikes N, Roan E, Webb D, Voeller GR (2018) The problem of seroma after ventral hernia repair. Surg Technol Int 32:93–98
White TJ, Santos MC, Thompson JS (1998) Factors affecting wound complications in repair of ventral hernias. Am Surg 64(3):276–280
Idrees M, Mare H, Lester L, Kariyawasam S (2021) Large ventral hernias: to drain… And what to drain… That is the question! ANZ J Surg 91(10):2081–2085
Miller BT, Tamer R, Petro CC, Krpata DM, Rosen MJ, Prabhu AS et al (2023) Retromuscular drain versus no drain in robotic retromuscular ventral hernia repair: a propensity score-matched analysis of the abdominal core health quality collaborative. Hernia 27(2):409–413
Krpata DM, Prabhu AS, Carbonell AM, Haskins IN, Phillips S, Poulose BK et al (2017) Drain placement does not increase infectious complications after retromuscular ventral hernia repair with synthetic mesh: an AHSQC analysis. J Gastrointest Surg 21(12):2083–2089
Marcolin P, de Figueiredo SMP, Constante MM, de Melo VMF, de Araújo SW, Mao RMD et al (2023) Drain placement in retromuscular ventral hernia repair: a systematic review and meta-analysis. Hernia 27(3):519–526
Owens CD, Stoessel K (2008) Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect 70(Suppl 2):3–10
Punjani R, Arora E, Mankeshwar R, Gala J (2021) An early experience with transversus abdominis release for complex ventral hernias: a retrospective review of 100 cases. Hernia 25(2):353–364
Maloney SR, Schlosser KA, Prasad T, Kasten KR, Gersin KS, Colavita PD et al (2019) Twelve years of component separation technique in abdominal wall reconstruction. Surgery 166(4):435–444
Maloney SR, Schlosser KA, Prasad T, Colavita PD, Kercher KW, Augenstein VA et al (2020) The impact of component separation technique versus no component separation technique on complications and quality of life in the repair of large ventral hernias. Surg Endosc 34(2):981–987
Tanaka EY, Yoo JH, Rodrigues AJ, Utiyama EM, Birolini D, Rasslan S (2010) A computerized tomography scan method for calculating the hernia sac and abdominal cavity volume in complex large incisional hernia with loss of domain. Hernia 14(1):63–69
Cobb WS, Warren JA, Ewing JA, Burnikel A, Merchant M, Carbonell AM (2015) Open retromuscular mesh repair of complex incisional hernia: predictors of wound events and recurrence. J Am Coll Surg 220(4):606–613
Hawn MT, Gray SH, Snyder CW, Graham LA, Finan KR, Vick CC (2011) Predictors of mesh explantation after incisional hernia repair. Am J Surg 202(1):28–33
Willemin M, Schaffer C, Kefleyesus A, Dayer A, Demartines N, Schäfer M et al (2023) Drain versus no drain in open mesh repair for incisional hernia, results of a prospective randomized controlled trial. World J Surg 47(2):461–468
Funding
There was no funding for this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Diego L Lima, Raquel Nogueira, Xinyan Zheng, Shannon Keisling, and Prashanth Sreeramoju have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lima, D.L., Keisling, S., Zheng, X. et al. Drain vs no drain placement after retromuscular ventral hernia repair with mesh: an ACHQC analysis. Surg Endosc 38, 3564–3570 (2024). https://doi.org/10.1007/s00464-024-10871-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-024-10871-2